Stockscreener 앱 받기
3.44
6.52%
-0.24
시간 외 거래:
3.46
0.02
+0.58%
Ac Immune Sa 주식(ACIU)의 최신 뉴스
How AC Immune SA stock benefits from tech adoption2025 Price Targets & Long Hold Capital Preservation Plans - ulpravda.ru
Can AC Immune SA stock beat market expectations this quarterMarket Growth Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
What insider purchases suggest about AC Immune SA (IMR) stockWeekly Trade Report & Stepwise Swing Trade Plans - ulpravda.ru
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Yahoo Finance
Why is AC Immune stock up over 23% today? - MSN
Short Interest in AC Immune (NASDAQ:ACIU) Grows By 94.4% - MarketBeat
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - MSN
Market Leaders: Will AC Immune SA stock split again soonMarket Trend Review & High Return Stock Watch Alerts - moha.gov.vn
AC Immune (STU:IMR) EV-to-OCF : -3.79 (As of Jan. 06, 2026) - GuruFocus
AC Immune (NASDAQ:ACIU) Trading Up 5%Should You Buy? - MarketBeat
Why ETFs are accumulating AC Immune SA (IMR) stockTechnical Breakout Signals & Free High Impact Stock Picks - bollywoodhelpline.com
Why AC Immune SA stock remains a top recommendationPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
New Highs: Will AC Immune SA stock recover faster than marketWeekly Investment Summary & Real-Time Volume Trigger Notifications - Улправда
How AC Immune SA stock responds to policy changesPortfolio Return Report & Daily Profit Maximizing Tips - Улправда
Why analysts upgrade AC Immune SA stock2025 Year in Review & AI Enhanced Market Trend Forecasts - Улправда
Will AC Immune SA stock split again soon2025 Risk Factors & High Accuracy Swing Trade Signals - DonanımHaber
Will AC Immune SA (IMR) stock boost dividends further2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Should I hold or sell AC Immune SA stock in 2025Market Performance Report & Consistent Income Trade Recommendations - DonanımHaber
Is AC Immune SA stock supported by strong fundamentals2025 Bull vs Bear & Free Community Consensus Stock Picks - Bölüm Sonu Canavarı
Recap Report: Why analysts upgrade AC Immune SA stockWeekly Investment Summary & Growth Oriented Trading Recommendations - ulpravda.ru
Aug Update: Will AC Immune SA stock recover faster than market2025 Market Sentiment & Safe Capital Allocation Plans - Улправда
AC Immune (STU:IMR) OCF Margin % : -1,953.03% (As of Sep. 2025) - GuruFocus
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD - Seeking Alpha
AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Performance Recap: Will AC Immune SA stock outperform growth indexesJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - moha.gov.vn
Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn
AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights
AC Immune reports promising phase 2 results for Parkinson’s therapy - MSN
AC Immune’s Parkinson’s vaccine advances on promising biomarker profile - BioCentury
AC Immune Simulates Curiosity in Neurodegenerative Fight with Global Conference Plans - StocksToTrade
AC Immune (ACIU) Stock: Surges as ACI-7104.056 Shows Potential in Early Parkinson’s Disease - parameter.io
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results - TipRanks
Why Is AC Immune Stock Up Over 23% Today? - Asianet Newsable
AC Immune SA: Navigating Market Momentum - timothysykes.com
ACIU Surges 30% on Positive Parkinson's Therapy Trial Results - GuruFocus
ACIU: ACI-7104.056 shows promise in slowing Parkinson's progression with strong safety and efficacy - TradingView
AC Immune’s Parkinson’s treatment shows promise in slowing disease - Investing.com
AC Immune surges on positive mid-stage trial data for Parkinson’s drug - Seeking Alpha
AC Immune (ACIU) Reports Encouraging Phase 2 Results for Parkins - GuruFocus
Ac Immune shares climb 32.6% premarket after co reports positive trial data for Parkinson's disease therapy - marketscreener.com
AC Immune stock rises after positive Parkinson’s disease trial data - Investing.com India
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy - TipRanks
AC Immune’s Parkinson’s treatment shows promise in slowing disease By Investing.com - Investing.com Canada
AC Immune Reports Positive Interim Phase 2 Data for ACI-7104.056 Indicating Potential to Slow Parkinson's Disease Progression - Quiver Quantitative
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - The Manila Times
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - GlobeNewswire Inc.
AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy - simplywall.st
Sentiment Watch: Will AC Immune SA stock deliver long term returns - moha.gov.vn
Aug Reactions: Why ETFs are accumulating AC Immune SA IMR stockEarnings Risk Summary & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Quarterly Risk: Why analysts upgrade AC Immune SA stock2025 Sector Review & Fast Momentum Stock Entry Tips - BỘ NỘI VỤ
How AC Immune SA (IMR) stock reacts to weak economyVolume Spike & Weekly High Potential Alerts - Newser
0.80%
4.56%
자본화:
|
볼륨(24시간):